| | |
| 4-A.__Health care practitioner.__"Health care practitioner" has | | the meaning provided in Title 24, section 2502, subsection 1-A. |
|
| | | Sec. C-19. 22 MRSA §8702, sub-§8, as enacted by PL 1995, c. 653, Pt. | | A, §2 and affected by §7, is amended to read: |
|
| | | 8. Payor. "Payor" means a 3rd-party payor or 3rd-party | | administrator. |
|
| | | Sec. C-20. 22 MRSA §8702, sub-§9-A is enacted to read: |
|
| | | 9-A.__Quality data.__"Quality data" means information on | | health care quality required to be submitted pursuant to section | | 8708-A. |
|
| | | Sec. C-21. 22 MRSA §8702, sub-§11, as amended by PL 2001, c. 677, §2, | | is further amended to read: |
|
| | | 11. Third-party payor. "Third-party payor" means a health | | insurer, nonprofit hospital, medical services organization or | | managed care organization licensed in the State or the plan | | established in chapter 854. "Third-party payor" does not include | | carriers licensed to issue limited benefit health policies or | accident, specified disease, vision, disability, long-term care, | or nursing home care or Medicare supplement policies. |
|
| | | Sec. C-22. 22 MRSA §8703, sub-§1, as amended by PL 2001, c. 457, §4, | | is further amended to read: |
|
| | | 1. Objective. The purpose purposes of the organization is | | are to create and maintain a useful, objective, reliable and | | comprehensive health information database that is used to improve | | the health of Maine citizens and to issue reports, as provided in | | section 8712. This database must be publicly accessible while | | protecting patient confidentiality and respecting providers of | care. The organization shall collect, process and, analyze and | report clinical and, financial, quality and restructuring data as | | defined in this chapter. |
|
| | | Sec. C-23. 22 MRSA §8704, sub-§1, ķA, as amended by PL 2001, c. 457, | | §7, is further amended to read: |
|
| | A. The board shall develop and implement data collection | | policies and procedures for the collection, processing, | | storage and analysis of clinical, financial, quality and | | restructuring data in accordance with this subsection for | | the following purposes: |
|
|